バイオテクノロジー 株
| シンボル | 名前 | 価格 | % (1D) | 取引高 | 時価総額 | 価格チャート (1D) â–¾ | |
|---|---|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc
|
509.86
|
+2.28% |
759.72K |
129.23B |
|
||
|
Moderna, Inc. Common Stock
|
238.14
|
+5.23% |
11.99M |
95.07B |
|
||
|
Regeneron Pharmaceuticals Inc
|
800.61
|
+2.86% |
472.51K |
82.43B |
|
||
|
argenx SE American Depositary Shares
|
849.15
|
+3.77% |
227.12K |
53.40B |
|
||
|
BeOne Medicines Ltd. American Depositary Shares
|
372.00
|
+5.84% |
358.80K |
42.08B |
|
||
|
Revolution Medicines, Inc. Common Stock
|
190.60
|
-1.51% |
734.22K |
40.85B |
|
||
|
Alnylam Pharmaceuticals, Inc.
|
233.41
|
+3.98% |
717.98K |
31.23B |
|
||
|
Royalty Pharma plc Class A Ordinary Shares
|
59.80
|
+1.36% |
1.38M |
26.63B |
|
||
|
Roivant Sciences Ltd. Common Shares
|
34.04
|
+1.25% |
1.51M |
24.59B |
|
||
|
Genmab A/S ADS
|
37.99
|
+2.98% |
2.62M |
23.36B |
|
||
|
Incyte Genomics Inc
|
113.83
|
+2.03% |
701.82K |
23.07B |
|
||
|
BioNTech SE American Depositary Share
|
90.17
|
+1.70% |
467.65K |
22.65B |
|
||
|
Insmed, Inc.
|
98.73
|
+0.96% |
1.43M |
21.56B |
|
||
|
Exelixis Inc
|
62.98
|
+3.25% |
1.43M |
15.60B |
|
||
|
Ascendis Pharma A/S Ordinary Share
|
227.25
|
+0.11% |
139.60K |
14.95B |
|
||
|
Jazz Pharmaceuticals, Inc.
|
214.26
|
+2.20% |
463.63K |
13.91B |
|
||
|
Halozyme Therapeutics, Inc.
|
121.51
|
+4.01% |
1.17M |
13.79B |
|
||
|
BridgeBio Pharma, Inc. Common Stock
|
67.11
|
+3.34% |
1.02M |
13.12B |
|
||
|
Corcept Therapeutics Inc.
|
114.10
|
-1.83% |
310.46K |
12.33B |
|
||
|
Summit Therapeutics Inc. Common Stock
|
15.38
|
+1.62% |
2.83M |
12.27B |
|
||
|
Bio-Techne Corp.
|
72.53
|
+0.04% |
1.62M |
11.37B |
|
||
|
BioMarin Pharmaceuticals Inc
|
56.69
|
+2.81% |
1.18M |
10.97B |
|
||
|
ImmunityBio, Inc. Common Stock
|
10.07
|
+1.66% |
13.13M |
10.68B |
|
||
|
Madrigal Pharmaceuticals, Inc. Common Stock
|
456.22
|
-0.82% |
99,693 |
10.54B |
|
||
|
Vaxcyte, Inc. Common Stock
|
65.71
|
-2.72% |
927.25K |
10.34B |
|
||
|
Krystal Biotech, Inc. Common Stock
|
331.66
|
+0.29% |
116.04K |
9.82B |
|
||
|
Twist Bioscience Corporation Common Stock
|
143.75
|
-2.98% |
2.48M |
9.53B |
|
||
|
Kymera Therapeutics, Inc. Common Stock
|
107.64
|
+0.75% |
196.58K |
8.95B |
|
||
|
Cytokinetics Inc.
|
64.09
|
+1.04% |
681.93K |
8.91B |
|
||
|
Protagonist Therapeutics, Inc
|
137.31
|
+0.76% |
266.21K |
8.89B |
|
||
|
Caris Life Sciences, Inc. Common Stock
|
31.23
|
+3.22% |
1.62M |
8.83B |
|
||
|
Axsome Therapeutics, Inc
|
164.31
|
+1.29% |
395.25K |
8.61B |
|
||
|
TG Therapeutics, Inc.
|
55.91
|
+2.84% |
954.80K |
8.56B |
|
||
|
ARROWHEAD PHARMACEUTICALS, INC.
|
58.52
|
+0.26% |
1.05M |
8.27B |
|
||
|
Abivax SA American Depositary Shares
|
92.25
|
+4.86% |
759.48K |
8.05B |
|
||
|
Spyre Therapeutics, Inc. Common Stock
|
78.89
|
+0.33% |
558.07K |
7.37B |
|
||
|
Ionis Pharmaceuticals, Inc. Common Stock
|
43.90
|
+2.81% |
932.91K |
7.30B |
|
||
|
Praxis Precision Medicines, Inc. Common Stock
|
247.00
|
+3.34% |
296.72K |
6.90B |
|
||
|
Iovance Biotherapeutics, Inc. Common Stock
|
14.32
|
+0.77% |
5.34M |
6.49B |
|
||
|
Belite Bio, Inc American Depositary Shares
|
154.38
|
+1.09% |
78,873 |
6.22B |
|
||
|
Rhythm Pharmaceuticals, Inc. Common Stock
|
88.41
|
+1.96% |
153.83K |
6.09B |
|
||
|
Ligand Pharmaceuticals Inc.
|
302.76
|
+2.63% |
107.84K |
6.04B |
|
||
|
Immunovant, Inc. Common Stock
|
27.70
|
-0.70% |
758.80K |
5.72B |
|
||
|
CG Oncology, Inc. Common stock
|
62.42
|
+0.94% |
238.03K |
5.53B |
|
||
|
Mirum Pharmaceuticals, Inc. Common Stock
|
82.44
|
+3.10% |
239.74K |
5.35B |
|
||
|
Kodiak Sciences Inc Common Stock
|
84.90
|
+4.70% |
697.13K |
5.34B |
|
||
|
Erasca, Inc. Common Stock
|
14.96
|
+1.77% |
2.41M |
5.23B |
|
||
|
PTC Therapeutics, Inc.
|
61.22
|
+2.60% |
373.81K |
5.11B |
|
||
|
Cogent Biosciences, Inc. Common Stock
|
29.24
|
+3.87% |
991.73K |
5.07B |
|
||
|
Travere Therapeutics, Inc. Common Stock
|
53.06
|
-0.39% |
990.39K |
5.00B |
|
||
|
CRISPR Therapeutics AG
|
51.51
|
+2.57% |
645.72K |
4.98B |
|
||
|
Scholar Rock Holding Corporation Common Stock
|
40.84
|
+3.13% |
850.89K |
4.97B |
|
||
|
Oruka Therapeutics, Inc. Common Stock
|
73.97
|
-3.54% |
445.72K |
4.90B |
|
||
|
Veradermics, Incorporated
|
114.36
|
+0.78% |
369.25K |
4.78B |
|
||
|
Definium Therapeutics, Inc. Common Shares
|
34.50
|
+0.76% |
746.50K |
4.64B |
|
||
|
Edgewise Therapeutics, Inc. Common Stock
|
38.01
|
+2.67% |
724.11K |
4.13B |
|
||
|
Dianthus Therapeutics, Inc. Common Stock
|
73.79
|
-1.30% |
390.96K |
4.13B |
|
||
|
AbCellera Biologics Inc. Common Shares
|
12.55
|
+1.50% |
4.03M |
4.07B |
|
||
|
Legend Biotech Corporation American Depositary Shares
|
19.72
|
+3.57% |
871.78K |
3.84B |
|
||
|
Relay Therapeutics, Inc. Common Stock
|
17.45
|
+2.29% |
895.83K |
3.82B |
|
||
|
Tango Therapeutics, Inc.
|
22.32
|
+0.59% |
1.51M |
3.76B |
|
||
|
Arcutis Biotherapeutics, Inc. Common Stock
|
28.61
|
+8.35% |
2.08M |
3.60B |
|
||
|
Telix Pharmaceuticals Limited American Depositary Shares
|
10.53
|
-1.17% |
95,096 |
3.58B |
|
||
|
Viking Therapeutics, Inc
|
26.96
|
+5.87% |
3.13M |
3.43B |
|
||
|
Tarsus Pharmaceuticals, Inc. Common Stock
|
73.12
|
+1.15% |
392.99K |
3.42B |
|
||
|
Acadia Pharmaceuticals Inc.
|
19.64
|
+2.00% |
578.27K |
3.38B |
|
||
|
Xenon Pharmaceuticals Inc
|
34.59
|
+2.04% |
648.46K |
3.35B |
|
||
|
IDEAYA Biosciences, Inc. Common Stock
|
33.87
|
+0.03% |
304.71K |
3.27B |
|
||
|
Parabilis Medicines, Inc. Common Stock
|
25.90
|
+0.04% |
289.51K |
3.20B |
|
||
|
Celcuity Inc. Common Stock
|
60.51
|
+1.02% |
853.86K |
2.96B |
|
||
|
Denali Therapeutics Inc. Common Stock
|
18.40
|
+2.97% |
671.18K |
2.94B |
|
||
|
Enliven Therapeutics, Inc. Common Stock
|
39.88
|
+1.51% |
505.53K |
2.92B |
|
||
|
Arcus Biosciences, Inc.
|
22.84
|
+1.38% |
591.16K |
2.91B |
|
||
|
Dyne Therapeutics, Inc. Common Stock
|
15.19
|
+1.00% |
987.21K |
2.84B |
|
||
|
Nurix Therapeutics, Inc. Common stock
|
24.75
|
+4.56% |
1.30M |
2.70B |
|
||
|
Zai Lab Limited American Depositary Shares
|
23.59
|
+4.82% |
327.06K |
2.65B |
|
||
|
Precigen, Inc. Common Stock
|
7.355
|
+0.00% |
2.03M |
2.63B |
|
||
|
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
20.96
|
+4.75% |
355.84K |
2.51B |
|
||
|
Beam Therapeutics Inc. Common Stock
|
24.25
|
+2.54% |
907.92K |
2.50B |
|
||
|
ADMA Biologics, Inc.
|
10.74
|
+3.92% |
1.14M |
2.41B |
|
||
|
MBX Biosciences, Inc. Common Stock
|
49.72
|
+1.84% |
117.29K |
2.39B |
|
||
|
SELLAS Life Sciences Group, Inc. Common Stock
|
11.41
|
-3.96% |
3.03M |
2.30B |
|
||
|
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
4.2191
|
+12.81% |
45.11M |
2.26B |
|
||
|
Celldex Therapeutics, Inc
|
28.76
|
+3.32% |
342.62K |
2.26B |
|
||
|
Harmony Biosciences Holdings, Inc. Common Stock
|
38.65
|
+3.03% |
270.15K |
2.25B |
|
||
|
Aurinia Pharmaceuticals Inc
|
16.76
|
+0.90% |
506.89K |
2.23B |
|
||
|
Viridian Therapeutics, Inc. Common Stock
|
19.59
|
+6.58% |
1.06M |
2.22B |
|
||
|
Disc Medicine, Inc. Common Stock
|
57.71
|
+3.53% |
129.64K |
2.22B |
|
||
|
Fortrea Holdings Inc. Common Stock
|
22.33
|
+4.64% |
1.05M |
2.12B |
|
||
|
Vericel Corporation
|
41.30
|
+2.61% |
203.08K |
2.11B |
|
||
|
Novavax Inc
|
12.81
|
+1.34% |
4.21M |
2.11B |
|
||
|
Pharvaris N.V. Ordinary Shares
|
29.47
|
-1.83% |
332.63K |
2.07B |
|
||
|
Immunome, Inc.
|
17.34
|
+0.83% |
406.75K |
2.05B |
|
||
|
Vera Therapeutics, Inc. Class A Common Stock
|
28.38
|
+6.13% |
572.86K |
2.05B |
|
||
|
Lakefront Biotherapeutics American Depositary Shares
|
30.00
|
+2.04% |
146.20K |
1.96B |
|
||
|
Mineralys Therapeutics, Inc. Common Stock
|
21.69
|
+4.48% |
451.36K |
1.92B |
|
||
|
Agios Pharmaceuticals, Inc.
|
32.09
|
+3.60% |
653.47K |
1.92B |
|
||
|
ADARx Pharmaceuticals, Inc. Common Stock
|
17.83
|
+0.73% |
285.48K |
1.90B |
|
||
|
Sarepta Therapeutics,, Inc. Common Stock
|
17.73
|
+5.32% |
1.87M |
1.87B |
|
||
|
Zymeworks Inc.
|
25.90
|
+4.56% |
283.65K |
1.86B |
|
||
|
UroGen Pharma Ltd. Ordinary Shares
|
37.22
|
+1.75% |
162.71K |
1.82B |
|
||
|
Palvella Therapeutics, Inc. Common Stock
|
125.52
|
+2.40% |
75,440 |
1.81B |
|
||
|
Mesoblast Limited American Depositary Shares
|
13.88
|
+0.62% |
90,167 |
1.80B |
|
||
|
Xencor, Inc.
|
24.08
|
+2.95% |
186.69K |
1.79B |
|
||
|
Vir Biotechnology, Inc. Common Stock
|
10.48
|
+0.67% |
749.25K |
1.77B |
|
||
|
Septerna, Inc. Common Stock
|
37.39
|
+2.95% |
110.17K |
1.75B |
|
||
|
Braveheart Bio, Inc. Common Stock
|
19.34
|
+0.05% |
462.85K |
1.74B |
|
||
|
Biohaven Ltd.
|
11.41
|
+4.39% |
636.82K |
1.72B |
|
||
|
Trevi Therapeutics, Inc. Common Stock
|
12.08
|
+0.17% |
690.55K |
1.72B |
|
||
|
Zenas BioPharma, Inc. Common Stock
|
25.57
|
+2.84% |
208.94K |
1.67B |
|
||
|
Nuvation Bio Inc.
|
4.745
|
+1.39% |
1.98M |
1.67B |
|
||
|
Intellia Therapeutics, Inc
|
11.71
|
+2.49% |
1.92M |
1.64B |
|
||
|
Generate Biomedicines, Inc. Common Stock
|
12.76
|
+1.92% |
601.37K |
1.64B |
|
||
|
Ocular Therapeutix, Inc.
|
7.295
|
+1.32% |
1.23M |
1.60B |
|
||
|
Structure Therapeutics Inc. American Depositary Shares
|
22.28
|
+1.83% |
616.58K |
1.59B |
|
||
|
Stoke Therapeutics, Inc. Common Stock
|
24.27
|
+4.32% |
251.34K |
1.57B |
|
||
|
Korsana Biosciences, Inc. Common Stock
|
34.32
|
+8.40% |
193.57K |
1.56B |
|
||
|
Innoviva, Inc. Common Stock
|
21.05
|
+0.36% |
226.58K |
1.52B |
|
||
|
Maze Therapeutics, Inc. Common Stock
|
27.34
|
+4.25% |
263.73K |
1.52B |
|
||
|
Immunocore Holdings plc American Depositary Shares
|
29.37
|
+3.63% |
99,228 |
1.51B |
|
||
|
Absci Corporation Common Stock
|
8.80
|
+0.69% |
2.25M |
1.51B |
|
||
|
Hemab Therapeutics Holdings, Inc. Common Stock
|
32.26
|
+7.73% |
160.61K |
1.51B |
|
||
|
uniQure N.V.
|
21.71
|
+3.53% |
709.06K |
1.51B |
|
||
|
Ultragenyx Pharmaceutical Inc.
|
15.11
|
+1.41% |
1.50M |
1.49B |
|
||
|
Kailera Therapeutics, Inc. Common Stock
|
11.48
|
+6.94% |
535.33K |
1.49B |
|
||
|
AnaptysBio, Inc. Common Stock
|
47.79
|
+2.40% |
91,787 |
1.43B |
|
||
|
Rapport Therapeutics, Inc. Common Stock
|
29.64
|
+4.62% |
140.14K |
1.42B |
|
||
|
Ascentage Pharma Group International American Depository Shares
|
14.55
|
-2.02% |
4,370 |
1.36B |
|
||
|
Omeros Corporation
|
18.73
|
+1.65% |
327.29K |
1.36B |
|
||
|
Inhibrx Biosciences, Inc. Common Stock
|
90.35
|
+5.97% |
91,809 |
1.33B |
|
||
|
Tyra Biosciences, Inc. Common Stock
|
19.14
|
+2.35% |
181.96K |
1.32B |
|
||
|
Oric Pharmaceuticals, Inc. Common Stock
|
12.48
|
+7.68% |
493.37K |
1.29B |
|
||
|
Nektar Therapeutics
|
37.66
|
+2.07% |
367.54K |
1.29B |
|
||
|
GH Research PLC Ordinary Shares
|
18.66
|
+0.54% |
159.99K |
1.28B |
|
||
|
Kardigan, Inc. Common Stock
|
13.47
|
-0.37% |
210.56K |
1.26B |
|
||
|
First Tracks Biotherapeutics, Inc. Ordinary Shares
|
34.82
|
+2.02% |
867.79K |
1.24B |
|
||
|
Taysha Gene Therapies, Inc. Common Stock
|
3.765
|
+7.26% |
2.24M |
1.23B |
|
||
|
Alpha Tau Medical Ltd. Ordinary Shares
|
13.16
|
-2.48% |
289.93K |
1.22B |
|
||
|
Syndax Pharmaceuticals, Inc.
|
13.49
|
-0.30% |
965.34K |
1.20B |
|
||
|
LB Pharmaceuticals Inc Common Stock
|
36.33
|
+6.84% |
504.37K |
1.17B |
|
||
|
Bicara Therapeutics Inc. Common Stock
|
17.50
|
+0.92% |
250.12K |
1.16B |
|
||
|
Vor Biopharma Inc. Common Stock
|
19.50
|
+4.00% |
376.97K |
1.15B |
|
||
|
Damora Therapeutics, Inc. Ordinary Shares
|
18.32
|
-0.60% |
98,062 |
1.13B |
|
||
|
Nanobiotix S.A. American Depositary Shares
|
22.11
|
+3.88% |
53,260 |
1.13B |
|
||
|
Replimune Group, Inc.
|
11.71
|
+2.77% |
780.45K |
1.10B |
|
||
|
Avalyn Pharma Inc. Common Stock
|
24.73
|
+4.39% |
55,603 |
1.10B |
|
||
|
Immatics N.V. Ordinary Shares
|
7.13
|
+1.86% |
633.37K |
1.09B |
|
||
|
Janux Therapeutics, Inc. Common Stock
|
17.40
|
+1.58% |
218.17K |
1.06B |
|
||
|
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
6.845
|
+4.50% |
806.51K |
1.02B |
|
||
|
Mannkind Corporation
|
3.135
|
+3.81% |
1.98M |
1.01B |
|
||
|
Savara Inc.
|
4.765
|
+0.11% |
814.52K |
979.02M |
|
||
|
SL Science Holding Limited Ordinary Shares
|
1.705
|
+10.00% |
100.01K |
956.10M |
|
||
|
Seaport Therapeutics, Inc. Common Stock
|
17.62
|
+5.64% |
83,934 |
943.21M |
|
||
|
MeiraGTx Holdings plc Ordinary Shares
|
9.77
|
+3.83% |
324.72K |
938.34M |
|
||
|
Latigo Biotherapeutics, Inc. Common Stock
|
14.00
|
-10.88% |
222.50K |
928.19M |
|
||
|
Aktis Oncology, Inc. Common stock
|
16.30
|
-1.15% |
280.73K |
906.60M |
|
||
|
Alto Neuroscience Inc.
|
22.88
|
+5.37% |
209.14K |
897.66M |
|
||
|
Rigel Pharmaceuticals Inc. (New)
|
47.31
|
+1.05% |
77,538 |
883.74M |
|
||
|
MoonLake Immunotherapeutics Class A Ordinary Shares
|
10.38
|
+2.37% |
423.13K |
883.41M |
|
||
|
Jade Biosciences, Inc. Common Stock
|
13.82
|
+2.83% |
377.27K |
878.92M |
|
||
|
Cullinan Therapeutics, Inc. Common Stock
|
13.62
|
-0.15% |
434.48K |
876.51M |
|
||
|
Kura Oncology, Inc.
|
9.78
|
+1.77% |
864.11K |
870.03M |
|
||
|
Verastem, Inc.
|
9.57
|
+24.12% |
9.10M |
866.69M |
|
||
|
Ardelyx, Inc.
|
3.315
|
+3.92% |
2.38M |
855.89M |
|
||
|
Arbutus Biopharma Corporation Common Stock
|
4.285
|
+2.27% |
968.82K |
848.88M |
|
||
|
Monte Rosa Therapeutics, Inc. Common Stock
|
9.9393
|
+1.01% |
372.47K |
847.96M |
|
||
|
Odyssey Therapeutics, Inc. Common Stock
|
17.49
|
+5.36% |
53,876 |
840.54M |
|
||
|
Corvus Pharmaceuticals, Inc.
|
9.88
|
+5.33% |
441.76K |
831.11M |
|
||
|
Alumis Inc. Common Stock
|
6.415
|
+5.86% |
1.09M |
830.33M |
|
||
|
SpyGlass Pharma, Inc. Common Stock
|
24.50
|
+3.42% |
8,917 |
819.48M |
|
||
|
ArriVent BioPharma, Inc. Common Stock
|
16.57
|
+2.27% |
227.29K |
816.91M |
|
||
|
Geron Corp
|
1.23
|
+3.36% |
2.29M |
790.24M |
|
||
|
Helus Pharma Inc.
|
10.73
|
+3.37% |
694.11K |
784.04M |
|
||
|
Ginkgo Bioworks Holdings, Inc.
|
11.52
|
-0.09% |
1.24M |
775.76M |
|
||
|
Adlai Nortye Group Ltd. American Depositary Shares
|
11.94
|
+9.74% |
472.23K |
768.91M |
|
||
|
Obsidian Therapeutics, Inc. Common Stock
|
12.22
|
+1.92% |
298.26K |
754.86M |
|
||
|
Sana Biotechnology, Inc. Common Stock
|
2.445
|
+4.94% |
1.48M |
731.94M |
|
||
|
Inventiva S.A. American Depository Shares
|
3.075
|
+7.14% |
1.90M |
726.42M |
|
||
|
Lexicon Pharmaceuticals, Inc.
|
1.625
|
+1.56% |
621.28K |
723.05M |
|
||
|
Immix Biopharma, Inc. Common Stock
|
8.67
|
+1.88% |
744.61K |
718.77M |
|
||
|
Apnimed, Inc. Common Stock
|
17.23
|
-3.37% |
1.01M |
717.30M |
|
||
|
Achieve Life Sciences, Inc.
|
6.865
|
-1.93% |
548.30K |
707.80M |
|
||
|
4D Molecular Therapeutics, Inc. Common Stock
|
12.59
|
+3.20% |
308.07K |
695.52M |
|
||
|
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
9.815
|
+1.82% |
2,693 |
694.69M |
|
||
|
Gyre Therapeutics, Inc. Common Stock
|
6.49
|
+0.31% |
55,773 |
688.16M |
|
||
|
Attovia Therapeutics, Inc. Common Stock
|
15.07
|
+0.74% |
324.90K |
687.96M |
|
||
|
MiMedx Group, Inc
|
4.705
|
+0.11% |
739.29K |
686.62M |
|
||
|
Candel Therapeutics, Inc. Common Stock
|
8.93
|
-1.54% |
508.55K |
683.31M |
|
||
|
OmniAb, Inc. Common Stock
|
4.645
|
+2.09% |
295.64K |
675.34M |
|
||
|
Annexon, Inc. Common Stock
|
3.555
|
-3.13% |
1.29M |
673.95M |
|
||
|
Aura Biosciences, Inc. Common Stock
|
6.32
|
+2.43% |
304.97K |
655.41M |
|
||
|
Avalo Therapeutics, Inc. Common Stock
|
12.16
|
+2.70% |
409.91K |
652.14M |
|
||
|
Prime Medicine, Inc. Common Stock
|
3.505
|
+11.98% |
4.33M |
635.73M |
|
||
|
Design Therapeutics, Inc. Common Stock
|
10.11
|
+3.91% |
169.99K |
632.70M |
|
||
|
Climb Bio, Inc. Common Stock
|
10.78
|
+4.76% |
249.04K |
619.16M |
|
||
|
Nuvectis Pharma, Inc. Common Stock
|
18.96
|
+5.33% |
64,192 |
618.91M |
|
||
|
Phathom Pharmaceuticals, Inc. Common Stock
|
7.625
|
+3.04% |
531.96K |
616.87M |
|
||
|
Wave Life Sciences Ltd. Ordinary Shares
|
3.125
|
+1.13% |
1.41M |
615.78M |
|
||
|
Zevra Therapeutics, Inc. Common Stock
|
10.28
|
+0.49% |
193.47K |
610.47M |
|
||
|
Solid Biosciences Inc. Common Stock
|
5.68
|
+3.93% |
920.55K |
609.04M |
|